Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 3/20 | 0.46 |
| ▸ | AHR | P35869 | 4/20 | 0.45 |
| ▸ | HTR2B | P41595 | 1/20 | 0.44 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.43 |
| ▸ | CNR2 | P34972 | 1/20 | 0.42 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.41 |
| ▸ | IDO1 | P14902 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.40 |
| ▸ | S100A4 | P26447 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4445059 | 0.88 | TP53 (0.48) | TP53AHRHTR2BPDE4DALDH1A1 | |
| SCHEMBL4459784 | 0.86 | TP53 (0.42) | TP53AHRHTR2BPDE4DALDH1A1 | |
| SCHEMBL4450570 | 0.86 | TP53 (0.46) | TP53AHRHTR2BPDE4DALDH1A1 | |
| SCHEMBL29618916 | 0.86 | TP53 (0.46) | TP53AHRHTR2BPDE4DALDH1A1 | |
| SCHEMBL4454535 | 0.81 | TP53 (0.52) | TP53AHRHTR2BPDE4DALDH1A1 | |
| SCHEMBL4459802 | 0.81 | AHR (0.61) | TP53AHRALDH1A1TSHRCYP3A4 | |
| SCHEMBL29489601 | 0.80 | TP53 (0.57) | TP53AHRHTR2BPDE4DALDH1A1 | |
| SCHEMBL2852592 | 0.80 | TP53 (0.57) | TP53AHRHTR2BPDE4DALDH1A1 | |
| SCHEMBL440944 | 0.79 | TP53 (0.61) | TP53AHRHTR2BPDE4DALDH1A1 | |
| SCHEMBL29364307 | 0.79 | TP53 (0.61) | TP53AHRHTR2BPDE4DALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220351865-A1 | METHODS OF BIOLOGICAL AGE EVALUATION AND SYSTEMS USING SUCH METHODS | GERO PTE. LTD. (SG) | 2022-11-03 | — | — | US | claimed |
| EP-3881907-A1 | METHOD FOR DECHLORINATION OF ONE OR MORE AROMATIC ORGANOCHLORINE COMPOUND(S) CONTAINED IN AN OIL OR FORMING SAID OIL - ASSOCIATED ELECTRICAL/ELECTRONIC DEVICE AND INSTALLATION | Université de Lille (FR) | 2021-09-22 | — | — | EP | claimed |
| CN-109191651-B | Internet of things administrative lock and control system thereof | 暨芯集成电路产业研究院 | 2024-08-13 | — | — | CN | disclosed |
| CN-117317722-B | Pop-up plug | 合肥中科微保可穿戴科技有限公司 | 2024-03-26 | — | — | CN | disclosed |
| CN-117317722-A | Pop-up plug | 合肥中科微保可穿戴科技有限公司 | 2023-12-29 | — | — | CN | disclosed |
| CN-111701144-B | Systems and methods for phototherapy modulation of nitric oxide | 诺欧生物有限责任公司 | 2023-03-21 | — | — | CN | disclosed |
| US-20230047816-A1 | PFKFB3 INHIBITORS AND THEIR USES | GERO PTE. LTD. (SG) | 2023-02-16 | — | — | US | disclosed |
| US-20220351865-A1 | METHODS OF BIOLOGICAL AGE EVALUATION AND SYSTEMS USING SUCH METHODS | GERO PTE. LTD. (SG) | 2022-11-03 | — | — | US | disclosed |
| CN-113286060-B | Monitoring camera with heater | 安讯士有限公司 | 2022-10-11 | — | — | CN | disclosed |
| US-20220227679-A1 | COMPOSITION FOR COATING SUBSTRATES | TRADE CORPORATION INTERNATIONAL, S.A. UNIPERSONAL (ES) | 2022-07-21 | — | — | US | disclosed |
| EP-3976557-A1 | COMPOSITION FOR COATING SUBSTRATES | Trade Corporation International, S.A. Unipersonal (ES) | 2022-04-06 | — | — | EP | disclosed |
| CN-216015541-U | Energy storage module | 上海派能能源科技股份有限公司 | 2022-03-11 | — | — | CN | disclosed |
| EP-3881907-A1 | METHOD FOR DECHLORINATION OF ONE OR MORE AROMATIC ORGANOCHLORINE COMPOUND(S) CONTAINED IN AN OIL OR FORMING SAID OIL - ASSOCIATED ELECTRICAL/ELECTRONIC DEVICE AND INSTALLATION | Université de Lille (FR) | 2021-09-22 | — | — | EP | disclosed |
| CN-111768814-A | Method for predicting POM-water distribution coefficient of organic pollutant based on quantitative structure-activity relationship | 扬州大学 | 2020-10-13 | — | — | CN | disclosed |
| US-20090269857-A1 | Instruments for detecting low-molecular weight substance | FUJIKURA KASEI CO., LTD. (JP) | 2009-10-29 | — | — | US | disclosed |
| US-20050148097-A1 | Instruments for detecting low-molecular weight substance | ENBIOTEC LABORATORIES C., LTD. (JP) | 2005-07-07 | — | — | US | disclosed |
| EP-1489420-A1 | INSTRUMENTS FOR DETECTING LOW-MOLECULAR WEIGHT SUBSTANCE | Enbiotec Laboratories Co., Ltd. (JP) | 2004-12-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230047816-A1 | PFKFB3 INHIBITORS AND THEIR USES | PFKFB3, PFKFB4, PFKFB1 | TP53 2372/4885AHR 3353/4885HTR2B 4156/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.